Evobrutinib Completed Phase 2 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03233230Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis
NCT02784106Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis